
Fintel is the tool people usually land on when a pure 13F tracker isn't enough — when you also want short interest, options flow, or activist filings in the same place. This post compares Fintel directly against AlphaSMO, the site you're reading this on, so you can decide whether Fintel's breadth is worth its subscription, or whether a narrower, free tool actually covers your real workflow.
| Fintel | AlphaSMO | |
|---|---|---|
| Data breadth | 13F, 13D/G, NPORT (funds/ETFs), UK disclosures, short interest, options flow | 13F, Form 4 insider, Form 144, 8-K, congressional STOCK Act trades |
| Pricing | Bronze $14.95/mo, Silver $29.75/mo, Gold $95/mo, Professional from $24.99/mo | $0 |
| Free tier | Limited views, most depth paywalled | Full site, no paywall |
| Short interest data | Yes | No |
| Options flow | Yes | No |
| Smart money convergence (13F + insider overlap) | No | Yes |
| Congressional trading tracker | No | Yes |
| Public REST API | Yes, paid | Yes, free |
| MCP server for AI agents | No | Yes |
| Proprietary scoring | Fintel Score | Convergence confidence score |
(Pricing and feature details reflect what's publicly listed on Fintel's site as of this writing — check their current pricing page before deciding, since plans change.)
Fintel's real strength isn't depth on any single filing type — it's that it aggregates several different regulatory data sources under one subscription: 13F institutional holdings, 13D/G activist stakes, NPORT data covering mutual funds and ETFs (which don't file 13Fs the same way hedge funds and asset managers do), UK regulatory disclosures, short interest, and options flow. That last two — short interest and options flow — are genuinely useful signals that neither AlphaSMO nor WhaleWisdom currently offers at all. If you're trying to triangulate a short-squeeze setup, or you want options positioning data alongside institutional ownership, Fintel is doing something the 13F-only tools in this space simply don't.
Its tiered pricing is also more approachable than a lot of the category: Bronze starts at $14.95/month, which is a real "try it for a month" price point rather than a quarterly commitment. And Fintel does have a public API — paywalled, but it exists, which puts it ahead of WhaleWisdom on that front even if it's behind AlphaSMO's free one.
If your actual need is short interest, options flow, or cross-referencing 13D/G and NPORT filings alongside 13F data, Fintel covers ground AlphaSMO doesn't touch today.
We don't track short interest or options flow, and we're not going to pretend we do. What we built instead:
Institutional + insider overlap, automatically. Fintel gives you 13F data and options/short data, but it doesn't specifically cross-reference institutional 13F buying against Form 4 insider buying in the same window — that's a narrower, more specific signal than "here's a pile of different filing types." AlphaSMO's convergence signal scans for tickers where both are happening together and scores the overlap. Live numbers as of this writing: Simon Property Group (SPG) shows a convergence score of 79.06 with 11 distinct institutional buyers; KKR shows 80.48 with 5 buyers; Elevance Health (ELV) and W.R. Berkley (WRB) both show 70.0 with 2 buyers each; International Paper (IP) shows 62.59 with 3 buyers. Live data, not a backtest, updating as filings land.
A free public API and MCP server. Fintel's API sits behind its paid tiers. AlphaSMO's API — covering 13F holdings, insider activity, stock flows, and the convergence signal — has no paywall at all, plus an MCP server so AI agents like Claude can query the data directly in conversation. If you're a developer or you're automating something rather than clicking through a dashboard, not having to pay for API access at all is the practical difference.
Congressional trading data. Fintel doesn't track STOCK Act disclosures. AlphaSMO does, as a separate but adjacent "who's positioning early" signal.
Zero cost, full access. Fintel's useful data mostly lives behind Silver ($29.75/mo, ~$357/yr) or Gold ($95/mo, ~$1,140/yr) — Bronze's cheaper tier is real but limited. AlphaSMO's equivalent functionality is free with no tier structure to climb.
Feature-list comparisons can make this look like a simple "who has more boxes checked" exercise, but the more useful framing is what you're actually trying to answer. If your question is "is this stock at risk of a short squeeze, and what's options positioning telling me," that's squarely Fintel's territory — AlphaSMO doesn't have an answer for that question at all today. If your question is "are institutions and this company's own insiders both quietly accumulating the same stock right now," that's the specific thing AlphaSMO's convergence signal was built to answer, and it's not something Fintel computes even though it has the underlying 13F and would need Form 4 data it doesn't currently track to do it. And if your question is "I want to pull this data into my own tool or spreadsheet without paying for API access," that's a clean point in AlphaSMO's favor regardless of the other two questions.
There's also a practical difference in who each tool is really built for. Fintel's breadth makes the most sense if you're already comfortable synthesizing several data types yourself — you pull short interest, check options flow, glance at 13D/G activity, and form your own view across all of it. That's a fine workflow, but it puts the cross-referencing work on you. AlphaSMO's convergence signal is closer to the opposite: it's a narrower dataset (13F plus Form 4, nothing else), but the cross-referencing is already done for you, scored, and served as one number you can sort and filter on. Neither approach is objectively better — one gives you more raw material to work with, the other gives you a pre-computed answer to one specific question.
Bronze at $14.95/month works out to about $180/year — genuinely affordable, and a reasonable way to get a first look at short interest and options data. But a lot of the cross-referencing value (seeing 13D/G activist stakes, NPORT fund data, and short interest together on one ticker, rather than checking each in isolation) tends to live in Silver and up. Silver runs about $357/year, Gold about $1,140/year. None of that is unreasonable for a platform pulling in and maintaining that many distinct regulatory data feeds — but it does mean the entry price you see advertised isn't necessarily the price of the feature set that made you consider Fintel in the first place. Read the tier breakdown carefully before assuming Bronze gets you everything described in Fintel's marketing.
If you can answer yes to any of these, lean Fintel: you need short interest or options flow data, you want 13D/G activist filings and NPORT fund/ETF data alongside 13F, or you specifically want UK regulatory disclosures in the mix. If you can answer yes to any of these instead, lean AlphaSMO: you want institutional and insider buying to be automatically cross-referenced rather than viewed separately, you want a completely free public API or MCP access instead of a paid one, you're interested in congressional trading data, or you don't want to pay anything to get meaningful access. If you answered yes to items on both lists, using both is a completely reasonable setup — a lot of serious researchers do exactly that.
Does AlphaSMO plan to add short interest or options flow? Not something we've committed to publicly. If that's a hard requirement today, Fintel is the better fit.
Is Fintel's Bronze tier actually usable, or a teaser? It's real access, but a meaningful amount of the deeper data (multi-filing cross-referencing, some historical depth) sits behind Silver and Gold — check the current feature breakdown by tier before assuming Bronze covers what you need.
Is AlphaSMO's API really free with no catch? Read access — holdings, insider activity, the convergence signal — has no paywall or signup wall today. Nothing described in this post sits behind payment.
Do people use both? Yes — Fintel for short interest, options flow, and the broader multi-filing-type view, AlphaSMO for the convergence signal, congress data, and free API access.
If you want to see the convergence signal for yourself, the smart money convergence page is free to browse, and the public API docs are open with no signup wall for read access.
An independent comparison of Fintel's paid multi-signal data platform and Dataroma's free curated superinvestor list — coverage, pricing, and who each is for.
An independent comparison of WhaleWisdom's paid 13F archive and Dataroma's free curated superinvestor list — when the free tool is enough, and when it isn't.
An independent comparison of WhaleWisdom and Fintel — historical depth vs data breadth, pricing tiers, backtesting, and which one fits which research workflow.